Kehinde M. Kuti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kehinde M. Kuti has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Bibilola Damilola Oladeji
College of Medicine, university of Ibadan
4 shared publications - Olutosin Awolude
Infectious Disease Institute, College of Medicine, University of Ibadan, Ibadan, Nigeria
4 shared publications - Aima Ahonkhai
Medical Practice Evaluation Center Massachusetts General Hospital Boston Massachusetts USA
3 shared publications - Lisa M. Kuhns
Department of Pediatrics, Feinberg School of Medicine & Ann & Robert H. Lurie Children’s Hospital of Chicago, Division of Adolescent and Young Adult Medicine, Northwestern University, Chicago, IL 60611, USA
3 shared publications - Robert Garofalo
Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
3 shared publications - Babafemi Taiwo
Feinberg School of Medicine, Northwestern University, Chicago, USA
2 shared publications
Latest Publications
- Open Access
- 3 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e74199
A Mobile Game Intervention for Young Persons Living With HIV and Depression in Nigeria: Protocol for a Pilot Randomized Controlled Trial
Background: Young people living with HIV bear a disproportionate burden of depression, which is associated with poor HIV outcomes. Problem-solving therapy (PST) has been shown to be effective for depression management and can be delivered with fidelity by nonspecialists, especially in resource-limited settings. PST is designed to equip individuals to manage the impact of stressful life events on their mental health. Change My Story is a narrative digital game designed to improve PST engagement among young people living with HIV in Nigeria. Objective: This trial will evaluate the impact of PST alone or PST with Change My Story on mental health outcomes among young people living with HIV in Nigeria. Methods: We will conduct a pilot hybrid implementation-effectiveness randomized controlled trial with 80 young people living with HIV (aged 16-24 years) in Nigeria with depression (9-item Patient Health Questionnaire [PHQ-9] ≥9) over 3 months. Participants will be randomized to receive PST with or without Change My Story. All participants will engage in weekly PST sessions for 6 weeks delivered by trained nonspecialists (clinic HIV adherence counselors). At 6 and 10-12 weeks, scores on PHQ-9 will determine the frequency of PST sessions during the remaining intervention period. Primary implementation outcomes, including engagement, satisfaction, feasibility, acceptability, and appropriateness from the participant perspective, will be assessed using validated scales, programmatic data, and focus group discussions at 3 months. Secondary clinical outcomes will assess changes in depressive symptoms, psychological distress, functional disability, antiretroviral therapy adherence, and HIV viral suppression at 3 and 6 months. Implementation outcomes (all but engagement and satisfaction) will be assessed through validated scales and focus group discussions from the implementer perspective at baseline and 6 months. Results: This study is funded by the US National Institutes of Health (funding commenced on March 8, 2024), institutional review board approval was received on April 15, 2024, and recruitment and data collection began in June 2025. Thus far, we have screened 103 youths and enrolled 23 participants. Among enrolled participants, 15 (65%) were male; 1 (4%) had a PHQ-9 score ≥17, and 6 (26%) had suicidal thoughts. We anticipate recruitment will be completed by January 2026 and follow-up by June 2026. We will assess our hypotheses that PST with Change My Story is feasible, acceptable, and appropriate and that individuals receiving PST integrated with Change My Story will have greater engagement, satisfaction, and depression remission compared to those receiving PST alone. Conclusions: This pilot randomized controlled trial attempts to establish preliminary data on the feasibility, acceptability, appropriateness, and efficacy of task-shifted PST and supplementary mobile health technology on improving HIV and mental health outcomes among young people living with HIV in Nigeria. These findings may serve as a basis for future large-scale interventions. Trial Registration: ClinicalTrials.gov NCT06389565; https://clinicaltrials.gov/study/NCT06389565 International Registered Report Identifier (IRRID): PRR1-10.2196/74199
- 3 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e74199
Open AccessA Mobile Game Intervention for Young Persons Living With HIV and Depression in Nigeria: Protocol for a Pilot Randomized Controlled Trial
Background: Young people living with HIV bear a disproportionate burden of depression, which is associated with poor HIV outcomes. Problem-solving therapy (PST) has been shown to be effective for depression management and can be delivered with fidelity by nonspecialists, especially in resource-limited settings. PST is designed to equip individuals to manage the impact of stressful life events on their mental health. Change My Story is a narrative digital game designed to improve PST engagement among young people living with HIV in Nigeria. Objective: This trial will evaluate the impact of PST alone or PST with Change My Story on mental health outcomes among young people living with HIV in Nigeria. Methods: We will conduct a pilot hybrid implementation-effectiveness randomized controlled trial with 80 young people living with HIV (aged 16-24 years) in Nigeria with depression (9-item Patient Health Questionnaire [PHQ-9] ≥9) over 3 months. Participants will be randomized to receive PST with or without Change My Story. All participants will engage in weekly PST sessions for 6 weeks delivered by trained nonspecialists (clinic HIV adherence counselors). At 6 and 10-12 weeks, scores on PHQ-9 will determine the frequency of PST sessions during the remaining intervention period. Primary implementation outcomes, including engagement, satisfaction, feasibility, acceptability, and appropriateness from the participant perspective, will be assessed using validated scales, programmatic data, and focus group discussions at 3 months. Secondary clinical outcomes will assess changes in depressive symptoms, psychological distress, functional disability, antiretroviral therapy adherence, and HIV viral suppression at 3 and 6 months. Implementation outcomes (all but engagement and satisfaction) will be assessed through validated scales and focus group discussions from the implementer perspective at baseline and 6 months. Results: This study is funded by the US National Institutes of Health (funding commenced on March 8, 2024), institutional review board approval was received on April 15, 2024, and recruitment and data collection began in June 2025. Thus far, we have screened 103 youths and enrolled 23 participants. Among enrolled participants, 15 (65%) were male; 1 (4%) had a PHQ-9 score ≥17, and 6 (26%) had suicidal thoughts. We anticipate recruitment will be completed by January 2026 and follow-up by June 2026. We will assess our hypotheses that PST with Change My Story is feasible, acceptable, and appropriate and that individuals receiving PST integrated with Change My Story will have greater engagement, satisfaction, and depression remission compared to those receiving PST alone. Conclusions: This pilot randomized controlled trial attempts to establish preliminary data on the feasibility, acceptability, appropriateness, and efficacy of task-shifted PST and supplementary mobile health technology on improving HIV and mental health outcomes among young people living with HIV in Nigeria. These findings may serve as a basis for future large-scale interventions. Trial Registration: ClinicalTrials.gov NCT06389565; https://clinicaltrials.gov/study/NCT06389565 International Registered Report Identifier (IRRID): PRR1-10.2196/74199
- Open Access
- 20 March 2025
- Published by JMIR Publications Inc. in JMIR Preprints
A Mobile Game Intervention for Young Persons Living With HIV and Depression in Nigeria: Protocol for a Pilot Randomized Controlled Trial (Preprint)
BACKGROUND Young people living with HIV bear a disproportionate burden of depression, which is associated with poor HIV outcomes. Problem-solving therapy (PST) has been shown to be effective for depression management and can be delivered with fidelity by nonspecialists, especially in resource-limited settings. PST is designed to equip individuals to manage the impact of stressful life events on their mental health. Change My Story is a narrative digital game designed to improve PST engagement among young people living with HIV in Nigeria. OBJECTIVE This trial will evaluate the impact of PST alone or PST with Change My Story on mental health outcomes among young people living with HIV in Nigeria. METHODS We will conduct a pilot hybrid implementation-effectiveness randomized controlled trial with 80 young people living with HIV (aged 16-24 years) in Nigeria with depression (9-item Patient Health Questionnaire [PHQ-9] ≥9) over 3 months. Participants will be randomized to receive PST with or without Change My Story. All participants will engage in weekly PST sessions for 6 weeks delivered by trained nonspecialists (clinic HIV adherence counselors). At 6 and 10-12 weeks, scores on PHQ-9 will determine the frequency of PST sessions during the remaining intervention period. Primary implementation outcomes, including engagement, satisfaction, feasibility, acceptability, and appropriateness from the participant perspective, will be assessed using validated scales, programmatic data, and focus group discussions at 3 months. Secondary clinical outcomes will assess changes in depressive symptoms, psychological distress, functional disability, antiretroviral therapy adherence, and HIV viral suppression at 3 and 6 months. Implementation outcomes (all but engagement and satisfaction) will be assessed through validated scales and focus group discussions from the implementer perspective at baseline and 6 months. RESULTS This study is funded by the US National Institutes of Health (funding commenced on March 8, 2024), institutional review board approval was received on April 15, 2024, and recruitment and data collection began in June 2025. Thus far, we have screened 103 youths and enrolled 23 participants. Among enrolled participants, 15 (65%) were male; 1 (4%) had a PHQ-9 score ≥17, and 6 (26%) had suicidal thoughts. We anticipate recruitment will be completed by January 2026 and follow-up by June 2026. We will assess our hypotheses that PST with Change My Story is feasible, acceptable, and appropriate and that individuals receiving PST integrated with Change My Story will have greater engagement, satisfaction, and depression remission compared to those receiving PST alone. CONCLUSIONS This pilot randomized controlled trial attempts to establish preliminary data on the feasibility, acceptability, appropriateness, and efficacy of task-shifted PST and supplementary mobile health technology on improving HIV and mental health outcomes among young people living with HIV in Nigeria. These findings may serve as a basis for future large-scale interventions. CLINICALTRIAL ClinicalTrials.gov NCT06389565; https://clinicaltrials.gov/study/NCT06389565 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/74199
- 20 March 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Mobile Game Intervention for Young Persons Living With HIV and Depression in Nigeria: Protocol for a Pilot Randomized Controlled Trial (Preprint)
BACKGROUND Young people living with HIV bear a disproportionate burden of depression, which is associated with poor HIV outcomes. Problem-solving therapy (PST) has been shown to be effective for depression management and can be delivered with fidelity by nonspecialists, especially in resource-limited settings. PST is designed to equip individuals to manage the impact of stressful life events on their mental health. Change My Story is a narrative digital game designed to improve PST engagement among young people living with HIV in Nigeria. OBJECTIVE This trial will evaluate the impact of PST alone or PST with Change My Story on mental health outcomes among young people living with HIV in Nigeria. METHODS We will conduct a pilot hybrid implementation-effectiveness randomized controlled trial with 80 young people living with HIV (aged 16-24 years) in Nigeria with depression (9-item Patient Health Questionnaire [PHQ-9] ≥9) over 3 months. Participants will be randomized to receive PST with or without Change My Story. All participants will engage in weekly PST sessions for 6 weeks delivered by trained nonspecialists (clinic HIV adherence counselors). At 6 and 10-12 weeks, scores on PHQ-9 will determine the frequency of PST sessions during the remaining intervention period. Primary implementation outcomes, including engagement, satisfaction, feasibility, acceptability, and appropriateness from the participant perspective, will be assessed using validated scales, programmatic data, and focus group discussions at 3 months. Secondary clinical outcomes will assess changes in depressive symptoms, psychological distress, functional disability, antiretroviral therapy adherence, and HIV viral suppression at 3 and 6 months. Implementation outcomes (all but engagement and satisfaction) will be assessed through validated scales and focus group discussions from the implementer perspective at baseline and 6 months. RESULTS This study is funded by the US National Institutes of Health (funding commenced on March 8, 2024), institutional review board approval was received on April 15, 2024, and recruitment and data collection began in June 2025. Thus far, we have screened 103 youths and enrolled 23 participants. Among enrolled participants, 15 (65%) were male; 1 (4%) had a PHQ-9 score ≥17, and 6 (26%) had suicidal thoughts. We anticipate recruitment will be completed by January 2026 and follow-up by June 2026. We will assess our hypotheses that PST with Change My Story is feasible, acceptable, and appropriate and that individuals receiving PST integrated with Change My Story will have greater engagement, satisfaction, and depression remission compared to those receiving PST alone. CONCLUSIONS This pilot randomized controlled trial attempts to establish preliminary data on the feasibility, acceptability, appropriateness, and efficacy of task-shifted PST and supplementary mobile health technology on improving HIV and mental health outcomes among young people living with HIV in Nigeria. These findings may serve as a basis for future large-scale interventions. CLINICALTRIAL ClinicalTrials.gov NCT06389565; https://clinicaltrials.gov/study/NCT06389565 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/74199
- Open Access
- 19 February 2025
- Published by Springer Nature in Global Implementation Research and Applications
- Vol. 5 (2) , 213-222
iTRAIN During iCARE Nigeria: Virtual Implementation Research Training Course Nested Within an Ongoing Trial
Background HIV clinicians and program implementers in Nigeria have limited implementation research training opportunities. We developed a virtual implementation research training program (iTRAIN) for clinicians and HIV program staff implementing the Intensive Combination Approach to Roll Back the Epidemic in Nigerian Adolescents (iCARE Nigeria) study. Methods iTRAIN was developed and facilitated by iCARE Nigeria investigators from Nigeria and the United States with extensive implementation research experience. The nine-session online course covered core principles of implementation research. incorporating developing a relevant concept note embedded into iCARE. Between September 2021–2022, content was delivered through asynchronous pre-recorded lectures and readings, followed by facilitator-led synchronous sessions. All six study site teams were assigned a course facilitator for mentoring to develop implementation research proposals nested in the iCARE study. We conducted pre- and post-training surveys to evaluate iTRAIN using the Kirkpatrick Framework and conducted analysis using explanatory mixed methods. Findings We enrolled 42 participants (55% male, 48% clinicians), with 50% of enrollees reporting no IR experience. Completion rate was 95%; 79% of participants rated the course overall as “excellent”, and 79% reported that their goal of gaining implementation research knowledge were met “a lot”. IR knowledge increased “a lot” in 71%, and 97% would “probably or definitely” use their iTRAIN knowledge in future research. All six sites developed implementation research concept notes addressing topics relevant to iCARE Nigeria, with four implemented. Conclusion iTRAIN represents a successful embedded implementation research virtual training and mentoring program which resulted in increased participant knowledge and capacity. Our training model can serve as a blueprint for study-embedded implementation research capacity-building in Nigeria and similar settings.
- 19 February 2025
- Published by Springer Nature in Global Implementation Research and Applications
- Vol. 5 (2) , 213-222
Open AccessiTRAIN During iCARE Nigeria: Virtual Implementation Research Training Course Nested Within an Ongoing Trial
Background HIV clinicians and program implementers in Nigeria have limited implementation research training opportunities. We developed a virtual implementation research training program (iTRAIN) for clinicians and HIV program staff implementing the Intensive Combination Approach to Roll Back the Epidemic in Nigerian Adolescents (iCARE Nigeria) study. Methods iTRAIN was developed and facilitated by iCARE Nigeria investigators from Nigeria and the United States with extensive implementation research experience. The nine-session online course covered core principles of implementation research. incorporating developing a relevant concept note embedded into iCARE. Between September 2021–2022, content was delivered through asynchronous pre-recorded lectures and readings, followed by facilitator-led synchronous sessions. All six study site teams were assigned a course facilitator for mentoring to develop implementation research proposals nested in the iCARE study. We conducted pre- and post-training surveys to evaluate iTRAIN using the Kirkpatrick Framework and conducted analysis using explanatory mixed methods. Findings We enrolled 42 participants (55% male, 48% clinicians), with 50% of enrollees reporting no IR experience. Completion rate was 95%; 79% of participants rated the course overall as “excellent”, and 79% reported that their goal of gaining implementation research knowledge were met “a lot”. IR knowledge increased “a lot” in 71%, and 97% would “probably or definitely” use their iTRAIN knowledge in future research. All six sites developed implementation research concept notes addressing topics relevant to iCARE Nigeria, with four implemented. Conclusion iTRAIN represents a successful embedded implementation research virtual training and mentoring program which resulted in increased participant knowledge and capacity. Our training model can serve as a blueprint for study-embedded implementation research capacity-building in Nigeria and similar settings.
- Open Access
- 10 January 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e71141
Exploratory Impact of iCARE Nigeria, a combined mHealth and Peer Navigation Intervention, on Depressive Symptoms and Substance Use Among Youth Living With HIV In Nigeria: a single-arm trial (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Mental health problems are a barrier to the wellbeing of youth living with HIV (YLWH). Many YLWH in Nigeria face peculiar bio-psycho-social vulnerabilities that predispose them to mental health problems including depression and substance use. In addition to improving treatment outcomes like medication adherence and linkage to care, peer engagement has shown some promise in improving the social and emotional wellbeing of this population. Mobile health (mHealth) interventions like SMS medication reminders may also contribute to better outcomes in YLWH. Emerging evidence suggests that combination interventions may be more effective than single interventions in improving key HIV testing and treatment outcomes among youth in Nigeria. Objective: To explore the impact of Intensive Combination Approach to Rollback the Epidemic in Nigerian Adolescents (iCARE Nigeria) study— an mHealth+peer navigation intervention primarily aimed at medication adherence and viral suppression— on depressive symptoms and substance use among YLWH in Nigeria Methods: A single-arm clinical trial was conducted at the Infectious Disease Institute (IDI), College of Medicine, University of Ibadan, Nigeria— primarily to improve medication adherence and viral suppression among YLWH attending its HIV clinic. The intervention combined peer navigation and daily, two-way, text message medication reminders delivered over a period of 48 weeks. Participants were screened at baseline and follow-up visits (24 and 48 weeks) for depression and substance use using standardized measures. Paired t-tests and McNemar’s tests were used to investigate the change in depressive symptoms and the change in the proportion of participants reporting substance use over time, respectively. Results: All 40 enrolled participants (50% male; mean age 19.9, SD 2.5 years) completed baseline and follow-up visits at week 24, while 37 (92.5%) participants completed the week 48 visit. Compared with baseline, there were significantly fewer self-reported depressive symptoms observed at 48 weeks (M= 2.89 vs 2.08, t36=2.04, 95%CI=0.006-1.615) but not at 24 weeks (M= 2.28 vs 2.62, t36=0.47, 95%CI=-0.742-1.442). There were fewer self-reports of substance use at weeks 24 and 48 when compared to baseline, but these were not statistically significant (OR=∞, 95%CI= 0.189-∞ and OR= 3.0, 95%CI=0.241-157.492 respectively). Conclusions: These findings suggest a statistically significant reduction in depressive symptoms among YLWH over the 48-week intervention period that may be due to the iCARE Nigeria intervention. However, given limitations such as low levels of depressive symptoms at baseline, small sample size, and the lack of a control group, future studies such as the randomised stepped wedge evaluation of the iCARE intervention are needed to provide better insights into these exploratory findings.
- 10 January 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e71141
Open AccessExploratory Impact of iCARE Nigeria, a combined mHealth and Peer Navigation Intervention, on Depressive Symptoms and Substance Use Among Youth Living With HIV In Nigeria: a single-arm trial (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Mental health problems are a barrier to the wellbeing of youth living with HIV (YLWH). Many YLWH in Nigeria face peculiar bio-psycho-social vulnerabilities that predispose them to mental health problems including depression and substance use. In addition to improving treatment outcomes like medication adherence and linkage to care, peer engagement has shown some promise in improving the social and emotional wellbeing of this population. Mobile health (mHealth) interventions like SMS medication reminders may also contribute to better outcomes in YLWH. Emerging evidence suggests that combination interventions may be more effective than single interventions in improving key HIV testing and treatment outcomes among youth in Nigeria. Objective: To explore the impact of Intensive Combination Approach to Rollback the Epidemic in Nigerian Adolescents (iCARE Nigeria) study— an mHealth+peer navigation intervention primarily aimed at medication adherence and viral suppression— on depressive symptoms and substance use among YLWH in Nigeria Methods: A single-arm clinical trial was conducted at the Infectious Disease Institute (IDI), College of Medicine, University of Ibadan, Nigeria— primarily to improve medication adherence and viral suppression among YLWH attending its HIV clinic. The intervention combined peer navigation and daily, two-way, text message medication reminders delivered over a period of 48 weeks. Participants were screened at baseline and follow-up visits (24 and 48 weeks) for depression and substance use using standardized measures. Paired t-tests and McNemar’s tests were used to investigate the change in depressive symptoms and the change in the proportion of participants reporting substance use over time, respectively. Results: All 40 enrolled participants (50% male; mean age 19.9, SD 2.5 years) completed baseline and follow-up visits at week 24, while 37 (92.5%) participants completed the week 48 visit. Compared with baseline, there were significantly fewer self-reported depressive symptoms observed at 48 weeks (M= 2.89 vs 2.08, t36=2.04, 95%CI=0.006-1.615) but not at 24 weeks (M= 2.28 vs 2.62, t36=0.47, 95%CI=-0.742-1.442). There were fewer self-reports of substance use at weeks 24 and 48 when compared to baseline, but these were not statistically significant (OR=∞, 95%CI= 0.189-∞ and OR= 3.0, 95%CI=0.241-157.492 respectively). Conclusions: These findings suggest a statistically significant reduction in depressive symptoms among YLWH over the 48-week intervention period that may be due to the iCARE Nigeria intervention. However, given limitations such as low levels of depressive symptoms at baseline, small sample size, and the lack of a control group, future studies such as the randomised stepped wedge evaluation of the iCARE intervention are needed to provide better insights into these exploratory findings.
- 9 December 2024
- Published by Springer Nature in AIDS and Behavior
- Vol. 29 (3) , 848-857
Risk Factors for Viral Non-suppression Among Youth Living with HIV in Nigeria: Findings from the iCARE Nigeria Study
Viral suppression with antiretroviral therapy (ART) is a critical component of UNAIDS objectives to end the HIV epidemic. Youth living with HIV (YLH) have worse viral suppression rates than adults. The aim of this study was to identify risk factors for viral non-suppression among YLH in Nigeria. A secondary analysis of enrollment data from the iCARE Nigeria study, collected April–October 2021 for 541 YLH comprised demographic, psychosocial, behavioral, clinical variables, and viral load quantification. Viral non-suppression was defined as viral load ≥ 200 copies/mL. Generalized linear models using Akaike information criterion for selection of indicator variables in a stepwise approach were used to determine the risk factors for viral non-suppression. The final analytic sample was 491 and the proportion of non-suppressed participants at baseline was 40%. In the final model, substance use (other than alcohol, tobacco and/or cannabis) (aOR = 3.20 [95% CI: 1.05, 10.34]), missed medication doses (aOR = 1.09 [95% CI: 1.04, 1.15]), and a higher number of self-reported medication barriers (e.g., forgot, busy, change in routine) (aOR = 1.08 [95% CI: 1.00, 1.16]) were associated with a higher likelihood of viral non-suppression. Being prescribed a first-line regimen (aOR = 0.28 [95% CI: 0.17, 0.44]), disclosure to at least one brother (aOR = 0.64 [95% CI: 0.42, 0.97]), and higher treatment outcome expectancies (e.g., taking medication will improve health) (aOR = 0.81 [95% CI: 0.66, 0.98]), were all associated with a lower likelihood of viral non-suppression. Viral non-suppression among YLH in Nigeria is associated with psychosocial and behavioral factors, including missed doses, medication barriers, treatment outcome expectancies, and disclosure, that are potential targets for intervention to achieve ART goals.
- 9 December 2024
- Published by Springer Nature in AIDS and Behavior
- Vol. 29 (3) , 848-857
Risk Factors for Viral Non-suppression Among Youth Living with HIV in Nigeria: Findings from the iCARE Nigeria Study
Viral suppression with antiretroviral therapy (ART) is a critical component of UNAIDS objectives to end the HIV epidemic. Youth living with HIV (YLH) have worse viral suppression rates than adults. The aim of this study was to identify risk factors for viral non-suppression among YLH in Nigeria. A secondary analysis of enrollment data from the iCARE Nigeria study, collected April–October 2021 for 541 YLH comprised demographic, psychosocial, behavioral, clinical variables, and viral load quantification. Viral non-suppression was defined as viral load ≥ 200 copies/mL. Generalized linear models using Akaike information criterion for selection of indicator variables in a stepwise approach were used to determine the risk factors for viral non-suppression. The final analytic sample was 491 and the proportion of non-suppressed participants at baseline was 40%. In the final model, substance use (other than alcohol, tobacco and/or cannabis) (aOR = 3.20 [95% CI: 1.05, 10.34]), missed medication doses (aOR = 1.09 [95% CI: 1.04, 1.15]), and a higher number of self-reported medication barriers (e.g., forgot, busy, change in routine) (aOR = 1.08 [95% CI: 1.00, 1.16]) were associated with a higher likelihood of viral non-suppression. Being prescribed a first-line regimen (aOR = 0.28 [95% CI: 0.17, 0.44]), disclosure to at least one brother (aOR = 0.64 [95% CI: 0.42, 0.97]), and higher treatment outcome expectancies (e.g., taking medication will improve health) (aOR = 0.81 [95% CI: 0.66, 0.98]), were all associated with a lower likelihood of viral non-suppression. Viral non-suppression among YLH in Nigeria is associated with psychosocial and behavioral factors, including missed doses, medication barriers, treatment outcome expectancies, and disclosure, that are potential targets for intervention to achieve ART goals.